Enveric Biosciences Establishes Australia-based Subsidiary to Accelerate its Lead Psilocin Prodrug Program Targeting Mental Health Indications
First-in-human clinical trial investigating Enveric’s lead product candidate, EB-373 targeting anxiety disorder expected to initiate…